Proshares Ultrashort Nasdaq Biotechnology ETF Forecast

Sell candidate since Jun 11, 2026 Loss -21.63%

The ProShares UltraShort Nasdaq ETF price gained 5.01% on the last trading day (Friday, 10th Jul 2026), rising from $12.59 to $13.22. During the last trading day the ETF fluctuated 5.63% from a day low at $12.62 to a day high of $13.33. The price has fallen in 6 of the last 10 days and is down by -9.6% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 14 thousand more shares were traded than the day before. In total, 27 thousand shares were bought and sold for approximately $359.34 thousand.

The ETF lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the ETF is expected to fall -16.80% during the next 3 months and, with a 90% probability hold a price between $10.20 and $14.02 at the end of this 3-month period.

BIS Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has risen 6.32%. Further rise is indicated until a new top pivot has been found. ProShares UltraShort Nasdaq has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ProShares UltraShort Nasdaq ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the ETF. On further gains, the ETF will meet resistance from the long-term Moving Average at $15.73. On a fall, the ETF will find some support from the short-term average at $12.88. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ProShares UltraShort Nasdaq ETF

ProShares UltraShort Nasdaq finds support from accumulated volume at $12.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this ETF is considered to be "very high risk". During the last day, the ETF moved $0.710 between high and low, or 5.63%. For the last week, the ETF has had daily average volatility of 3.56%.

ProShares UltraShort Nasdaq is oversold on RSI14 (19). Some ETFS may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIS) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect ProShares UltraShort Nasdaq Biotechnology to open at $13.06, and during the day (based on 14 day Average True Range), to move between $12.94 and $13.49, which gives a possible trading interval of +/-$0.548 (+/-4.23%) up or down from last closing price. If ProShares UltraShort Nasdaq Biotechnology takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.67 (4.13%) than the resistance at $14.87 (12.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ProShares UltraShort Nasdaq Biotechnology ETF A Buy?

ProShares UltraShort Nasdaq holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this ETF.

Current score: -2.284 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $13.06 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk